Page 1 of 8
High Resolution Copy Number Analysis of Parkinson’s
Samples Using Nexus Copy Number and Roche
NimbleGen Microarrays
A WHITE PAPER FROM
BioDiscovery, Inc. and Roche NimbleGen, Inc.
September 2008
There was a problem loading this page.
Page 2 of 8
BioDiscovery Inc. Roche NimbleGen, Inc.
BioDiscovery Tel: 310-414-8100 | Roche NimbleGen Tel: +1 608-218-7600 Page 2
Introduction
The goal of this study was to utilize high-resolution comparative genomic hybridization (CGH)
technologies to identify functional mutations associated with Parkinson’s disease. Results from this
study identified a disease-causing microdeletion within the PARK2 gene in an affected individual. The
data for this study was generously provided by Dr. Christopher E. Mason of Yale Medical School working
in Dr. Matthew State’s laboratory. The details of the study have been published in Human Mutation
(2007 Dec; 28(12):1236-40).
Genomic DNA from an affected patient was prepared and co-hybridized with normal human genomic
DNA (pool of 6 individuals) on two different NimbleGenTM 385K arrays. The first array was the Human
CGH 385K Whole-Genome Tiling catalog array (6270bp median probe spacing) provided by Roche
NimbleGen, Inc. The second array was a focused Human Chromosome 6-specific array consisting of 385K
probes (404bp median probe spacing). We processed both arrays using Nexus Copy NumberTM
Professional version 3.1 and report the findings below.
Identification of a PARK2 Deletion
The raw data were normalized using Roche NimbleGen’s NimbleScanTM software and subsequently
processed in Nexus Copy NumberTM using the built-in Rank Segmentation algorithm. Identical
parameters were set for both the “Whole-Genome” and the “Focused” arrays. As shown in figure 1,
both samples show a common deletion on chromosome 6. It is also interesting to note that the higher- resolution focused array (Array 104418) identified additional copy number changes on chromosome 6.
The whole-genome array (Array 89695) shows copy number changes at a number of different loci
throughout the genome, such as on Chromosomes 1, 8, 9, 12, 15, 17, 20 and 22.